| Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation CM Keck, RH Müller European journal of pharmaceutics and biopharmaceutics 62 (1), 3-16, 2006 | 1375 | 2006 |
| Challenges and solutions for the delivery of biotech drugs–a review of drug nanocrystal technology and lipid nanoparticles RH Muller, CM Keck Journal of biotechnology 113 (1-3), 151-170, 2004 | 1065 | 2004 |
| State of the art of nanocrystals–special features, production, nanotoxicology aspects and intracellular delivery RH Müller, S Gohla, CM Keck European journal of pharmaceutics and biopharmaceutics 78 (1), 1-9, 2011 | 767 | 2011 |
| Production and characterization of Hesperetin nanosuspensions for dermal delivery PR Mishra, L Al Shaal, RH Müller, CM Keck International journal of pharmaceutics 371 (1-2), 182-189, 2009 | 369 | 2009 |
| Polyhydroxy surfactants for the formulation of lipid nanoparticles (SLN and NLC): effects on size, physical stability and particle matrix structure A Kovacevic, S Savic, G Vuleta, RH Mueller, CM Keck International journal of pharmaceutics 406 (1-2), 163-172, 2011 | 343 | 2011 |
| Development of an oral rutin nanocrystal formulation R Mauludin, RH Müller, CM Keck International journal of pharmaceutics 370 (1-2), 202-209, 2009 | 300 | 2009 |
| Natural nanoparticles: a particular matter inspired by nature S Griffin, MI Masood, MJ Nasim, M Sarfraz, AP Ebokaiwe, KH Schäfer, ... Antioxidants 7 (1), 3, 2017 | 229 | 2017 |
| Kinetic solubility and dissolution velocity of rutin nanocrystals R Mauludin, RH Müller, CM Keck European Journal of Pharmaceutical Sciences 36 (4-5), 502-510, 2009 | 203 | 2009 |
| Nanotoxicological classification system (NCS)–a guide for the risk-benefit assessment of nanoparticulate drug delivery systems CM Keck, RH Müller European Journal of Pharmaceutics and Biopharmaceutics 84 (3), 445-448, 2013 | 189 | 2013 |
| Size analysis of submicron particles by laser diffractometry—90% of the published measurements are false CM Keck, RH Müller International journal of pharmaceutics 355 (1-2), 150-163, 2008 | 179 | 2008 |
| Development of curcumin nanocrystal: physical aspects H Rachmawati, L Al Shaal, RH Müller, CM Keck Journal of pharmaceutical sciences 102 (1), 204-214, 2013 | 170 | 2013 |
| Preservation of nanostructured lipid carriers (NLC) WM Obeidat, K Schwabe, RH Müller, CM Keck European Journal of Pharmaceutics and Biopharmaceutics 76 (1), 56-67, 2010 | 169 | 2010 |
| Twenty years of drug nanocrystals: where are we, and where do we go? RH Müller, CM Keck European journal of pharmaceutics and biopharmaceutics: official journal of …, 2011 | 148 | 2011 |
| Drug delivery to the brain–realization by novel drug carriers RH Müller, CM Keck Journal of nanoscience and nanotechnology 4 (5), 471-483, 2004 | 146 | 2004 |
| Skin photoprotection improvement: synergistic interaction between lipid nanoparticles and organic UV filters S Nikolić, CM Keck, C Anselmi, RH Müller International journal of pharmaceutics 414 (1-2), 276-284, 2011 | 123 | 2011 |
| Solid lipid nanoparticles (SLN) stabilized with polyhydroxy surfactants: Preparation, characterization and physical stability investigation AB Kovačević, RH Müller, SD Savić, GM Vuleta, CM Keck Colloids and Surfaces A: Physicochemical and Engineering Aspects 444, 15-25, 2014 | 116 | 2014 |
| Nanostructured lipid carriers (NLC): the second generation of solid lipid nanoparticles RH Müller, U Alexiev, P Sinambela, CM Keck Percutaneous penetration enhancers chemical methods in penetration …, 2016 | 115 | 2016 |
| Resveratrol nanosuspensions for dermal application–production, characterization, and physical stability S Kobierski, K Ofori-Kwakye, RH Müller, CM Keck Die Pharmazie-An International Journal of Pharmaceutical Sciences 64 (11 …, 2009 | 105 | 2009 |
| Second generation of drug nanocrystals for delivery of poorly soluble drugs: smartCrystals technology C Keck, S Kobierski, R Mauludin, RH Müller Dosis 24 (2), 124-128, 2008 | 105 | 2008 |
| Ultra-small NLC for improved dermal delivery of coenyzme Q10 JC Schwarz, N Baisaeng, M Hoppel, M Löw, CM Keck, C Valenta International journal of pharmaceutics 447 (1-2), 213-217, 2013 | 101 | 2013 |
